Date: 2010-03-29 18:24:31Pharmacology Food and Drug Administration Drug safety Rofecoxib Sulfones David Graham Pharmaceutical industry Celecoxib The New England Journal of Medicine COX-2 inhibitors Pharmaceutical sciences Medicine | | Testimony of David J. Graham, MD, MPH, November 18, 2004 Mr. Chairman and members of the Committee, Introduction. Good morning. My name is David Graham, and I am pleased to come before youAdd to Reading ListSource URL: www.finance.senate.govDownload Document from Source Website File Size: 28,34 KBShare Document on Facebook
|